Table 3.
Unweighted | Weighted | |||||
---|---|---|---|---|---|---|
Model | HR | 95% CI | p-Value | HR | 95% CI | p-Value |
Outcome: Eating disorder (composite) | ||||||
Transfeminine | 0.74 | 0.55, 1.00 | 0.047 | 1.31 | 0.91, 1.89 | 0.141 |
Transmasculine | 0.37 | 0.31, 0.43 | <0.001 | 0.62** | 0.51, 0.75 | <0.001 |
Outcome: Anorexia nervosa | ||||||
Transfeminine | 0.41 | 0.18, 0.95 | 0.037 | 1.23 | 0.46, 3.31 | 0.684 |
Transmasculine | 0.3 | 0.21, 0.41 | <0.001 | 0.44** | 0.31, 0.63 | <0.001 |
Outcome: Bulimia | ||||||
Transfeminine | 0.62 | 0.25, 1.57 | 0.315 | 1.14 | 0.43, 3.01 | 0.791 |
Transmasculine | 0.55 | 0.35, 0.85 | 0.007 | 0.84 | 0.51, 1.38 | 0.496 |
Outcome: Binge eating | ||||||
Transfeminine | 1.01 | 0.41, 2.52 | 0.98 | 1.5 | 0.58, 3.90 | 0.402 |
Transmasculine | 0.77 | 0.48, 1.25 | 0.296 | 1.01 | 0.59, 1.75 | 0.962 |
Time-dependent Cox proportional hazards model on the outcome of a diagnosis of an eating disorder including Anorexia nervosa, Bulimia, Binge eating (analyzed as individual outcomes and as composite), among patients without any gender-affirming medical therapy (NI; reference group), to patients receiving surgical intervention (SX). Result shown both before and after inverse probability treatment weighting.
** Significant.